AngioDynamics Statistics
Total Valuation
AngioDynamics has a market cap or net worth of $481.21 million. The enterprise value is $461.53 million.
Important Dates
The last earnings date was Thursday, October 2, 2025, before market open.
| Earnings Date | Oct 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AngioDynamics has 41.20 million shares outstanding. The number of shares has increased by 1.49% in one year.
| Current Share Class | 41.20M |
| Shares Outstanding | 41.20M |
| Shares Change (YoY) | +1.49% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 3.56% |
| Owned by Institutions (%) | 71.49% |
| Float | 32.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.62 |
| Forward PS | 1.54 |
| PB Ratio | 2.76 |
| P/TBV Ratio | 4.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.29 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 9.82 |
| Debt / FCF | n/a |
| Interest Coverage | -5,812.25 |
Financial Efficiency
Return on equity (ROE) is -17.10% and return on invested capital (ROIC) is -7.44%.
| Return on Equity (ROE) | -17.10% |
| Return on Assets (ROA) | -5.20% |
| Return on Invested Capital (ROIC) | -7.44% |
| Return on Capital Employed (ROCE) | -11.78% |
| Revenue Per Employee | $445,508 |
| Profits Per Employee | -$47,553 |
| Employee Count | 675 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 2.17 |
Taxes
| Income Tax | -107,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +76.71% in the last 52 weeks. The beta is 0.49, so AngioDynamics's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +76.71% |
| 50-Day Moving Average | 11.21 |
| 200-Day Moving Average | 10.12 |
| Relative Strength Index (RSI) | 56.26 |
| Average Volume (20 Days) | 456,363 |
Short Selling Information
The latest short interest is 2.81 million, so 6.81% of the outstanding shares have been sold short.
| Short Interest | 2.81M |
| Short Previous Month | 2.71M |
| Short % of Shares Out | 6.81% |
| Short % of Float | 8.76% |
| Short Ratio (days to cover) | 4.88 |
Income Statement
In the last 12 months, AngioDynamics had revenue of $300.72 million and -$32.10 million in losses. Loss per share was -$0.78.
| Revenue | 300.72M |
| Gross Profit | 162.84M |
| Operating Income | -23.25M |
| Pretax Income | -32.21M |
| Net Income | -32.10M |
| EBITDA | -1.61M |
| EBIT | -23.25M |
| Loss Per Share | -$0.78 |
Full Income StatementBalance Sheet
The company has $38.76 million in cash and $9.60 million in debt, giving a net cash position of $29.16 million or $0.71 per share.
| Cash & Cash Equivalents | 38.76M |
| Total Debt | 9.60M |
| Net Cash | 29.16M |
| Net Cash Per Share | $0.71 |
| Equity (Book Value) | 178.86M |
| Book Value Per Share | 4.32 |
| Working Capital | 88.37M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.79 million and capital expenditures -$9.82 million, giving a free cash flow of -$17.61 million.
| Operating Cash Flow | -7.79M |
| Capital Expenditures | -9.82M |
| Free Cash Flow | -17.61M |
| FCF Per Share | -$0.43 |
Full Cash Flow StatementMargins
Gross margin is 54.15%, with operating and profit margins of -7.73% and -10.67%.
| Gross Margin | 54.15% |
| Operating Margin | -7.73% |
| Pretax Margin | -10.71% |
| Profit Margin | -10.67% |
| EBITDA Margin | -0.54% |
| EBIT Margin | -7.73% |
| FCF Margin | n/a |
Dividends & Yields
AngioDynamics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.49% |
| Shareholder Yield | -1.49% |
| Earnings Yield | -6.54% |
| FCF Yield | -3.59% |
Analyst Forecast
The average price target for AngioDynamics is $19.33, which is 65.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.33 |
| Price Target Difference | 65.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 7.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AngioDynamics has an Altman Z-Score of 1.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.46 |
| Piotroski F-Score | 4 |
